Literature DB >> 30152289

Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes.

Maryam Farzaneh1, Fatemeh Rahimi2, Masoumeh Alishahi2, Seyed E Khoshnam3.   

Abstract

Cardiovascular Disease (CVD) is one of the world-wide healthcare problem that involves the heart or blood vessels. CVD includes myocardial infarction and coronary artery diseases (CAD). Dysfunctional myocardial cells are leading causes of low cardiac output or ventricular dysfunction after cardiac arrest and may contribute to the progression of CVD which could not generate new cardiomyocytes in human adult heart. The mesenchymal stem cells (MSCs) which are present in adult marrow can self-renew and have the capacity of differentiation into multiple types of cells including cardiomyocytes. Recent biochemical analyses greatly revealed that several regulators of MSCs, such as HGF, PDGF, Wnt, and Notch-1 signaling pathways have been shown to be involved in the proliferation and differentiation into cardiomyocytes. Preclinical studies are paving the way for further applications of MSCs in the repair of myocardial infarction. In this study, we discuss and summarize the paracrine mechanisms involved in MSCs differentiation into cardiomyocytes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cardiomyocytes; Cardiovascular disease (CVP); Mesenchymal stem cells (MSCs); Paracrinezzm321990mechanisms; Signaling pathways; myocardial infarction.

Mesh:

Substances:

Year:  2019        PMID: 30152289     DOI: 10.2174/1574888X13666180821160421

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  9 in total

1.  Functions of Mesenchymal Stem Cells in Cardiac Repair.

Authors:  Selçuk Öztürk; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Mechanotransduction in Mesenchymal Stem Cells (MSCs) Differentiation: A Review.

Authors:  Narmadaa Raman; Siti A M Imran; Khairul Bariah Ahmad Amin Noordin; Wan Safwani Wan Kamarul Zaman; Fazlina Nordin
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 3.  Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease.

Authors:  Anthony Matta; Vanessa Nader; Marine Lebrin; Fabian Gross; Anne-Catherine Prats; Daniel Cussac; Michel Galinier; Jerome Roncalli
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

Review 4.  WNT signaling in atrial fibrillation.

Authors:  Carmen Wolke; Elmer Antileo; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

Review 5.  The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease.

Authors:  Chuanbin Liu; Dong Han; Ping Liang; Yang Li; Feng Cao
Journal:  Front Cell Dev Biol       Date:  2021-04-22

Review 6.  Cardiac tissue engineering: state-of-the-art methods and outlook.

Authors:  Anh H Nguyen; Paul Marsh; Lauren Schmiess-Heine; Peter J Burke; Abraham Lee; Juhyun Lee; Hung Cao
Journal:  J Biol Eng       Date:  2019-06-28       Impact factor: 4.355

7.  Small G protein signaling modulator 3 (SGSM3) knockdown attenuates apoptosis and cardiogenic differentiation in rat mesenchymal stem cells exposed to hypoxia.

Authors:  Seung Eun Jung; Jung-Won Choi; Hanbyeol Moon; Sena Oh; Soyeon Lim; Seahyoung Lee; Sang Woo Kim; Ki-Chul Hwang
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

8.  Decellularized Human Dermal Matrix as a Biological Scaffold for Cardiac Repair and Regeneration.

Authors:  Immacolata Belviso; Veronica Romano; Anna Maria Sacco; Giulia Ricci; Diana Massai; Marcella Cammarota; Angiolina Catizone; Chiara Schiraldi; Daria Nurzynska; Mara Terzini; Alessandra Aldieri; Gianpaolo Serino; Fabrizio Schonauer; Felice Sirico; Francesco D'Andrea; Stefania Montagnani; Franca Di Meglio; Clotilde Castaldo
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20

Review 9.  Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.

Authors:  Kamila Raziyeva; Aiganym Smagulova; Yevgeniy Kim; Saltanat Smagul; Ayan Nurkesh; Arman Saparov
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.